President Trump Links Tylenol to Autism, Prompting Legal and Medical Responses
President Trump's recent statements connecting Tylenol use during pregnancy to autism have led to increased legal actions and widespread medical criticism.
President Donald Trump recently suggested a link between acetaminophen (Tylenol) use during pregnancy and an increased risk of autism in children. This assertion has led to a surge in legal inquiries and widespread criticism from the medical community.
Attorney Ashley Keller, representing clients in a product liability lawsuit against Tylenol's manufacturer, Kenvue, reported a significant increase in potential clients following the president's remarks. Keller's firm is appealing a 2023 court decision that excluded expert testimony alleging a connection between prenatal acetaminophen exposure and autism. The appeal is scheduled for oral arguments on October 6.
Medical experts have strongly refuted the president's claims. The American College of Obstetricians and Gynecologists emphasized that acetaminophen remains the recommended treatment for fever and pain during pregnancy. Additionally, the American Academy of Pediatrics stated that the announcement was "filled with dangerous claims and misleading information that sends a confusing message to parents and expecting parents."
The Food and Drug Administration (FDA) announced plans to update safety labels for acetaminophen products, acknowledging some studies suggest an association between the drug and autism but noting that causation has not been established. The FDA also highlighted that untreated fever during pregnancy can pose risks to fetal development.
In a related development, the FDA is initiating the approval process for leucovorin, a folic acid derivative, as a potential treatment for autism-related folate deficiencies. While some small studies have shown marginal improvements, researchers emphasize the need for larger, rigorous trials to confirm efficacy.
The president's statements have also drawn criticism for potentially undermining public trust in established medical guidelines and treatments. Experts caution against making health decisions based on unverified claims and stress the importance of consulting healthcare professionals for medical advice.